Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 285

1.

Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study.

Siegmund T, Blankenfeld H, Schumm-Draeger PM.

Diabetes Technol Ther. 2009 Aug;11(8):523-8. doi: 10.1089/dia.2009.0048.

PMID:
19698066
[PubMed - indexed for MEDLINE]
2.
3.

A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes.

McKay M, Compion G, Lytzen L.

Diabetes Technol Ther. 2009 Mar;11(3):195-201. doi: 10.1089/dia.2008.0054.

PMID:
19267582
[PubMed - indexed for MEDLINE]
4.

Patient perceptions of injection pain and anxiety: a comparison of NovoFine 32-gauge tip 6mm and Micro Fine Plus 31-gauge 5mm needles.

Iwanaga M, Kamoi K.

Diabetes Technol Ther. 2009 Feb;11(2):81-6. doi: 10.1089/dia.2008.0027.

PMID:
19848573
[PubMed - indexed for MEDLINE]
6.

Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.

Haak T, Edelman S, Walter C, Lecointre B, Spollett G.

Clin Ther. 2007 Apr;29(4):650-60.

PMID:
17617288
[PubMed - indexed for MEDLINE]
7.

Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.

Aronson R, Gibney MA, Oza K, Bérubé J, Kassler-Taub K, Hirsch L.

Clin Ther. 2013 Jul;35(7):923-933.e4. doi: 10.1016/j.clinthera.2013.05.020. Epub 2013 Jun 20.

PMID:
23790553
[PubMed - indexed for MEDLINE]
Free Article
8.

Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus.

Niskanen L, Jensen LE, Råstam J, Nygaard-Pedersen L, Erichsen K, Vora JP.

Clin Ther. 2004 Apr;26(4):531-40.

PMID:
15189750
[PubMed - indexed for MEDLINE]
9.

Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes.

Hirsch LJ, Gibney MA, Albanese J, Qu S, Kassler-Taub K, Klaff LJ, Bailey TS.

Curr Med Res Opin. 2010 Jun;26(6):1531-41. doi: 10.1185/03007995.2010.482499.

PMID:
20429832
[PubMed - indexed for MEDLINE]
10.

Patient acceptance and issues of education of two durable insulin pen devices.

Asakura T, Seino H, Jensen KH.

Diabetes Technol Ther. 2008 Aug;10(4):299-304. doi: 10.1089/dia.2007.0268.

PMID:
18715204
[PubMed - indexed for MEDLINE]
11.

Comparison between shorter straight and thinner microtapered insulin injection needles.

Nagai Y, Ohshige T, Arai K, Kobayashi H, Sada Y, Ohmori S, Furukawa K, Kato H, Kawata T, Ohta A, Tanaka Y.

Diabetes Technol Ther. 2013 Jul;15(7):550-5. doi: 10.1089/dia.2012.0334. Epub 2013 Apr 26.

PMID:
23621793
[PubMed - indexed for MEDLINE]
12.

Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes.

Kreugel G, Keers JC, Kerstens MN, Wolffenbuttel BH.

Diabetes Technol Ther. 2011 Jul;13(7):737-41. doi: 10.1089/dia.2011.0010. Epub 2011 Apr 10.

PMID:
21476936
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Biologic material in needles and cartridges after insulin injection with a pen in diabetic patients.

Le Floch JP, Herbreteau C, Lange F, Perlemuter L.

Diabetes Care. 1998 Sep;21(9):1502-4.

PMID:
9727898
[PubMed - indexed for MEDLINE]
14.

An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.

Stockl K, Ory C, Vanderplas A, Nicklasson L, Lyness W, Cobden D, Chang E.

Curr Med Res Opin. 2007 Jan;23(1):133-46.

PMID:
17257475
[PubMed - indexed for MEDLINE]
15.

Preference for a new prefilled insulin pen compared with the original pen.

Garg S, Bailey T, DeLuzio T, Pollom D.

Curr Med Res Opin. 2011 Dec;27(12):2323-33. doi: 10.1185/03007995.2011.630721. Epub 2011 Oct 31.

PMID:
21988614
[PubMed - indexed for MEDLINE]
16.

Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe.

Molife C, Lee LJ, Shi L, Sawhney M, Lenox SM.

Diabetes Technol Ther. 2009 Aug;11(8):529-38. doi: 10.1089/dia.2009.0007. Review.

PMID:
19698067
[PubMed - indexed for MEDLINE]
17.

Functionality and acceptability of a new electronic insulin injection pen with a memory feature.

Venekamp WJ, Kerr L, Dowsett SA, Johnson PA, Wimberley D, McKenzie C, Malone J, Milicevic Z.

Curr Med Res Opin. 2006 Feb;22(2):315-25.

PMID:
16466603
[PubMed - indexed for MEDLINE]
18.

Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens.

Chancellor J, Aballéa S, Lawrence A, Sheldon R, Cure S, Plun-Favreau J, Marchant N.

Pharmacoeconomics. 2008;26(3):217-34.

PMID:
18282016
[PubMed - indexed for MEDLINE]
19.

Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.

Asche CV, Shane-McWhorter L, Raparla S.

Diabetes Technol Ther. 2010 Jun;12 Suppl 1:S101-8. doi: 10.1089/dia.2009.0180. Review.

PMID:
20515297
[PubMed - indexed for MEDLINE]
20.

Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.

Clin Ther. 2007;29 Spec No:1294-305.

PMID:
18046929
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk